These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37752678)

  • 21. Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
    Gaba F; Oxley S; Liu X; Yang X; Chandrasekaran D; Kalsi J; Antoniou A; Side L; Sanderson S; Waller J; Ahmed M; Wallace A; Wallis Y; Menon U; Jacobs I; Legood R; Marks D; Manchanda R
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the quality and communicative aspects of patient decision aids for early-stage breast cancer treatment: a systematic review.
    Vromans R; Tenfelde K; Pauws S; van Eenbergen M; Mares-Engelberts I; Velikova G; van de Poll-Franse L; Krahmer E
    Breast Cancer Res Treat; 2019 Nov; 178(1):1-15. PubMed ID: 31342311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantity over quality-Findings from a systematic review and environmental scan of patient decision aids on early abortion methods.
    Donnelly KZ; Elwyn G; Thompson R
    Health Expect; 2018 Feb; 21(1):316-326. PubMed ID: 28881071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
    Flaum N; Morgan RD; Burghel GJ; Bulman M; Clamp AR; Hasan J; Mitchell CL; Badea D; Moon S; Hogg M; Hadjiyiannakis D; Clancy T; Schlecht H; Woodward ER; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Lalloo FI; Harkness EF; Evans DGR
    Eur J Hum Genet; 2020 Nov; 28(11):1541-1547. PubMed ID: 32651552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
    Sawka AM; Straus S; Rodin G; Heus L; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Segal P; Gafni A; Thorpe KE; Goldstein DP
    Cancer; 2015 Oct; 121(20):3717-26. PubMed ID: 26195199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention.
    Gaba F; Blyuss O; Liu X; Goyal S; Lahoti N; Chandrasekaran D; Kurzer M; Kalsi J; Sanderson S; Lanceley A; Ahmed M; Side L; Gentry-Maharaj A; Wallis Y; Wallace A; Waller J; Luccarini C; Yang X; Dennis J; Dunning A; Lee A; Antoniou AC; Legood R; Menon U; Jacobs I; Manchanda R
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
    Rahman B; Lanceley A; Kristeleit RS; Ledermann JA; Lockley M; McCormack M; Mould T; Side L
    J Med Genet; 2019 Mar; 56(3):195-198. PubMed ID: 29535157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
    Gaba F; Blyuss O; Chandrasekaran D; Osman M; Goyal S; Gan C; Izatt L; Tripathi V; Esteban I; McNicol L; Ragupathy K; Crawford R; Evans DG; Legood R; Menon U; Manchanda R
    BJOG; 2021 Mar; 128(4):714-726. PubMed ID: 32803845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer.
    Sadinsky MB; Power J; Ambrosio E; Palma L; Zeng X; Foulkes WD; Weber E
    Curr Oncol; 2022 May; 29(5):3565-3575. PubMed ID: 35621678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
    Plaskocinska I; Shipman H; Drummond J; Thompson E; Buchanan V; Newcombe B; Hodgkin C; Barter E; Ridley P; Ng R; Miller S; Dann A; Licence V; Webb H; Tan LT; Daly M; Ayers S; Rufford B; Earl H; Parkinson C; Duncan T; Jimenez-Linan M; Sagoo GS; Abbs S; Hulbert-Williams N; Pharoah P; Crawford R; Brenton JD; Tischkowitz M
    J Med Genet; 2016 Oct; 53(10):655-61. PubMed ID: 27208206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.
    Harmsen MG; Steenbeek MP; Hoogerbrugge N; van Doorn HC; Gaarenstroom KN; Vos MC; Massuger LFAG; de Hullu JA; Hermens RPMG
    Health Expect; 2018 Jun; 21(3):659-667. PubMed ID: 29281161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
    Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
    Trials; 2015 May; 16():231. PubMed ID: 26012700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
    Kautz-Freimuth S; Redaèlli M; Rhiem K; Vodermaier A; Krassuski L; Nicolai K; Schnepper M; Kuboth V; Dick J; Vennedey V; Wiedemann R; Schmutzler R; Stock S
    BMC Med Inform Decis Mak; 2021 Jun; 21(1):180. PubMed ID: 34090422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.
    Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
    Support Care Cancer; 2018 Nov; 26(11):3739-3748. PubMed ID: 29752528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
    Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
    Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Bennett CL; Barry MJ; Col NF; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Légaré F; Thomson R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD001431. PubMed ID: 21975733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Zdenkowski N; Butow P; Spillane A; Douglas C; Snook K; Jones M; Oldmeadow C; Fewster S; Beckmore C; Boyle FM;
    J Natl Compr Canc Netw; 2018 Apr; 16(4):378-385. PubMed ID: 29632057
    [No Abstract]   [Full Text] [Related]  

  • 38. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
    Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.